New Delhi: Despite misgivings of health activists, the central health ministry remains committed to controversial injectable contraceptives for women.
Union health minister JP Nadda, while answering questions in the Lok Sabha, listed injectable contraceptives as one of the new measures the Centre had taken for its family planning programme.
The more immediate side effects range from menstrual irregularity, amenorrhea, weight gain, headaches, dizziness, decrease in sex drive, bloating, as mentioned in a series of reports and in a paper in the Economic and Political Weekly.
Yet, on Friday, when a series of questions about India's family planning programme came up, Nadda listed injectable contraceptives as one of the new measures being pushed out by the Centre this year, along with Mission Parivar Vikas.
There had been 3,767 failures in 2013-14, 5928 in 2014-15 and 7960 in 2015-16. The amount of complications in 2013-14 were 437, 134 in 2014-15 and 78 in 2015-16.
The ministry also detailed its expenditure on family planning, Rs 69046.06 lakh in 2014-15 and Rs 77057.88 lakhs in 2015-16, centred mostly on 10 high focus states: Bihar, Chhattisgarh, Himachal Pradesh, Jammu & Kashmir, Jharkhand, Madhya Pradesh, Odisha, Rajasthan, Uttar Pradesh, Uttarakhand. However, these amounts have also come under criticism.
Comments
0 comment